Amerise Biosciences Ltd — Board Meeting, 24-07-2025: Board Meeting

Amerise Biosciences' board has approved the financial results for the recent quarter. This important update provides stakeholders with insight into the company's operational performance. For the quarter, the company recorded revenue from operations of approximately 0.06 Cr. After accounting for total expenses of about 0.07 Cr, the company reported a net loss of approximately 0.01 Cr. These figures are key for investors to assess the company's current financial health and its trajectory in the market.